Oramed Pharmaceuticals

$4.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.22 (+37.77%) Today
-$0.10 (-2.25%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell ORMP and other stocks, options, and ETFs commission-free!

About ORMP

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY. The listed name for ORMP is Oramed Pharmaceuticals Inc. Common Stock.

CEO
Nadav Kidron
Employees
12
Headquarters
New York, New York
Founded
2002
Market Cap
105.36M
Price-Earnings Ratio
Dividend Yield
Average Volume
229.46K
High Today
$5.15
Low Today
$3.44
Open Price
$3.52
Volume
7.14M
52 Week High
$6.05
52 Week Low
$2.40

Collections

ORMP Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Dec 8, After Hours

You May Also Like